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Chronic sustained hypoxia (CH) induces structural and functional adaptations in
respiratory muscles of animal models, however the underlying molecular mechanisms
are unclear. This study explores the putative role of CH-induced redox remodeling
in a translational mouse model, with a focus on the sternohyoid—a representative
upper airway dilator muscle involved in the control of pharyngeal airway caliber.
We hypothesized that exposure to CH induces redox disturbance in mouse
sternohyoid muscle in a time-dependent manner affecting metabolic capacity and
contractile performance. C57Bl6/J mice were exposed to normoxia or normobaric
CH (FiO =2 0.1) for 1, 3, or 6 weeks. A second cohort of animals was
exposed to CH for 6 weeks with and without antioxidant supplementation (tempol
or N-acetyl cysteine in the drinking water). Following CH exposure, we performed
2D redox proteomics with mass spectrometry, metabolic enzyme activity assays, and
cell-signaling assays. Additionally, we assessed isotonic contractile and endurance
properties ex vivo. Temporal changes in protein oxidation and glycolytic enzyme
activities were observed. Redox modulation of sternohyoid muscle proteins key
to contraction, metabolism and cellular homeostasis was identified. There was no
change in redox-sensitive proteasome activity or HIF-1α content, but CH decreased
phospho-JNK content independent of antioxidant supplementation. CH was detrimental
to sternohyoid force- and power-generating capacity and this was prevented by
chronic antioxidant supplementation. We conclude that CH causes upper airway
dilator muscle dysfunction due to redox modulation of proteins key to function and
homeostasis. Such changes could serve to further disrupt respiratory homeostasis
in diseases characterized by CH such as chronic obstructive pulmonary disease.
Antioxidants may have potential use as an adjunctive therapy in hypoxic respiratory
disease.
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Introduction
The striated muscles of breathing are the final common effec-
tors of the respiratory control system, critical in the mainte-
nance of respiratory homeostasis. Pharyngeal dilator muscles are
an important subset of the respiratory muscles serving to con-
trol the patency of the upper airway. Pharyngeal dilator muscle
damage or dysfunction increases the risk of obstructive airway
events. Upper airway muscle dysfunction is implicated in human
obstructive sleep apnea (OSA), a common respiratory disorder
characterized by repeated occlusions of the pharyngeal airway
during sleep. Of note, OSA is prevalent in patients with chronic
obstructive pulmonary disease (COPD), presenting as the “over-
lap syndrome” (Owens et al., 2008; McNicholas, 2009; Owens
and Malhotra, 2010), but the reasons for the emergence of this
co-morbidity are unclear.
Chronic sustained hypoxia (CH) is a dominant feature of
respiratory diseases including COPD, but the putative role of
CH in respiratory muscle remodeling and dysfunction is gen-
erally under-explored. Little is known about the effects of CH
exposure on the respiratory muscles and there exists a general
paucity of information concerning the pharyngeal dilator mus-
cles despite the potential clinical relevance. Respiratory and limb
muscle remodeling are features of COPD (Orozco-Levi, 2003;
Doucet et al., 2004, 2010; Levine et al., 2013) and interestingly,
exposure to CH elicits differential structural and functional adap-
tations in respiratory and limb muscles (El-Khoury et al., 2003,
2012; Faucher et al., 2005; McMorrow et al., 2011; Gamboa and
Andrade, 2012; Carberry et al., 2014). We speculate that hypoxic
remodeling of respiratory muscle has relevance to respiratory
muscle plasticity in respiratory disease. Hypoxia-related remod-
eling of upper airway muscles may underpin poor upper airway
control in COPD.
Pharyngeal dilator muscles are phasically active during inspi-
ration and muscle activity is increased during hypoxic exposure
(O’Halloran et al., 2002; Edge et al., 2014). Contractile activ-
ity increases reactive oxygen species (ROS) production which
are pivotal for muscle adaptation to high altitude and respira-
tory diseases characterized by hypoxia (Zuo and Clanton, 2005;
Marin-Corral et al., 2009; Murray, 2009; Chaudhary et al., 2012;
El-Khoury et al., 2012; Levine et al., 2013; Puig-Vilanova et al.,
2015). Thus, CH likely challenges respiratory muscles, includ-
ing the pharyngeal dilator muscles, with enhanced ROS on two
fronts—increased contractile activity during reflex hyperventila-
tion and hypoxia per se. We postulated a role for ROS in elicit-
ing CH-induced redox remodeling of key muscle proteins with
resultant functional changes in the sternohyoid muscle—a repre-
sentative pharyngeal dilator muscle. The supra- and infra-hyoid
muscles of the upper airway control the position of the hyoid
bone, displacing it anteriorly during inspiration to enlarge the
caliber of the pharynx. Sternohyoid muscle length correlates to
airway volume (Van Lunteren et al., 1987) and the muscle is
recruited during increased respiratory drive (O’Halloran et al.,
2002) and obstructive airway events (Edge et al., 2012). Ster-
nohyoid muscle damage is reported in the English bulldog, an
animal model of OSA (Petrof et al., 1994). We have extensively
characterized sternohyoid muscle physiology (O’Halloran, 2006;
Skelly et al., 2010; Shortt and O’Halloran, 2014; McDonald et al.,
2015), including several studies in animal models of chronic
hypoxia (Bradford et al., 2005; McMorrow et al., 2011; Skelly
et al., 2011, 2012a,b, 2013; O’Connell et al., 2013; Carberry et al.,
2014; McDonald et al., 2014). The sternohyoid muscle is suited to
ex vivo study of contractile function due to ease of access, longi-
tudinal arrangement of its fibers and the opportunity, employed
in the present study, to keep bony origin and insertions intact in
isolated preparations.
Given that ventilation, muscle contractile behavior, and the
level of hypoxia experienced by the respiratory muscles, are likely
temporally modified during the process of acclimatization to
CH, we characterized protein carbonyl and free thiol content
(the most common and most specific form of protein oxidation
respectively (Dalle-Donne et al., 2006; El-Shafey et al., 2011) in
the sternohyoid after 1, 3, or 6 weeks of CH exposure. In addi-
tion, we sought to identify redox-modified proteins in the ster-
nohyoid muscle after 6 weeks of CH using 2D redox proteomics
combined with mass spectrometry (Cole et al., 2014; Hu et al.,
2014; Rainville et al., 2014) having reasoned that this informa-
tion will aid the determination of how and where ROS exert
their effects in muscle cells following CH exposure. We postu-
lated that chymotrypsin-like activity of the 20S proteasome is
increased in the sternohyoid after 6 weeks of CH given that pro-
teasomal activity is highly sensitive to ROS (McClung et al., 2008;
Aiken et al., 2011). Hypoxia through the hypoxia-inducible factor
(HIF)-1α transcription factor promotes a more glycolytic pheno-
type in tissues to reduce the reliance on oxygen in ATP produc-
tion (Howald et al., 1990; Murray, 2009; Wheaton and Chandel,
2011). HIF expression correlates withmuscle fiber type and activ-
ity and is also modulated by ROS. Therefore, we reasoned that
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and lac-
tate dehydrogenase (LDH) activities would be temporally mod-
ified in the sternohyoid in response to CH exposure. We also
assessed HIF-1α content, phospho-MAPK content (p38, JNK,
ERK1/2), and sternohyoid isotonic contractile and endurance
properties ex vivo after 6 weeks of CH in the presence or absence
of chronic antioxidant supplementation with tempol or N-acetyl
cysteine (NAC). We tested the hypothesis that CH causes aber-
rant redox modulation of sternohyoid muscle function which is
reversible by antioxidant supplementation.
Materials and Methods
Ethical Approval
All protocols involving animals described in this study were
approved by local ethics committee and were performed under
license from the Irish Government Department of Health and
Children in accordance with EU legislation.
Animal Model
In the first series of experiments, 48 adult male C576Bl/J mice
(Charles River Laboratories, UK) were exposed to 1, 3, or 6 weeks
of CH (FiO2 = 0.1) or normoxia (6 groups: n = 8 per group,
matched for age and weight) in environmental chambers (Oxy-
Cycler Model A84, BioSpherix Ltd, USA) with precise control
of ambient oxygen concentration. All mice were housed at room
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temperature on a 12:12-h light–dark cycle. Food and water were
available ad libitum, and the chambers were opened briefly once
a week for cleaning. In a second series, 32 adult male C576Bl/J
mice were exposed to normoxia or CH with or without antioxi-
dant supplementation with tempol or NAC for 6 weeks (4 groups:
n = 8 per group, matched for age and weight). At the end of the
gas treatment periods, animals were anesthetized by 5% isoflu-
rane inhalation in oxygen and euthanized by cervical disloca-
tion. Blood samples were taken in capillary tubes for hematocrit
determination.
Molecular Studies
Tissue Preparation for Molecular Studies
Sternohyoid muscles were excised, snap frozen in liquid nitro-
gen and stored at −80◦C. Frozen muscle samples were homog-
enized in 10% w/v modified radioimmunoprecipitation (RIPA)
assay buffer (1X RIPA, 200mM sodium fluoride, 1mM phenyl-
methylsulfonyl fluoride, protease inhibitor cocktail, phosphatase
inhibitor cocktail (Fisher Scientific, Ireland) and centrifuged at
13,000 g for 15min to separate the insoluble fraction from
crude protein homogenate. Protein concentrations were evalu-
ated using a bicinchoninic assay (Pierce Biotechnology (Fisher
Scientific), Ireland) against bovine serum albumin standards.
Two additional muscles, the soleus and extensor digitorum
longus (EDL), slow and fast fiber type limb muscles respec-
tively, were also prepared in this manner for determination of
total protein carbonyl and free thiol content for comparison to
sternohyoid.
Total Protein Carbonyl and Free Thiol Content
As previously described (Cole et al., 2014; Hu et al., 2014;
Rainville et al., 2014), muscle homogenates were incubated
with either 2mMfluorescein-thiosemicarbazide (FTSC) or 2mM
iodoacetamidofluorescein (IAF) (Sigma-Aldrich Co., Ireland) for
2 h in the dark on ice for detection of free protein carbonyl and
thiol groups respectively. Samples were then precipitated with
20% trichloroacetic acid (TCA) in acetone, followed by centrifu-
gation at 11,000 g for 3min. Protein pellets were then washed
with ice-cold excess 1:1 ethylacetate/ethanol or acetone (for FTSC
and IAF respectively) to remove excess TCA, interfering salts and
non-protein contaminants. Samples were dried, re-suspended in
sample buffer containing 5% beta-mercaptoethanol and heated at
95◦C for 5min before electrophoretic separation on a 12% poly-
acrylamide gel (1D). Fluorescent images of the gels were captured
on a Typhoon Trio+ Variable-Mode Imager (GE Healthcare,
UK). Protein bands were visualized by colloidal coomassie stain-
ing (Dyballa and Metzger, 2009) and images were captured on a
calibrating image densitometer (GS-800, Bio-Rad, USA).
2D Redox Proteomics
As previously described (Cole et al., 2014; Hu et al., 2014;
Rainville et al., 2014), this method separates proteins accord-
ing to their isoelectric point and molecular mass such that
they appear as spots when stained on polyacrylamide gels; pro-
tein spots can be analyzed independently. Briefly, sternohy-
oid muscle samples were treated as described above for 1D
preparation until re-suspension in sample buffer. Samples were
instead re-suspended in rehydration buffer (7M urea, 2M
thiourea, 2% (w/v) 3-[(3-Cholamidopropyl)dimethylammonio]-
1-propanesulfonate, 4% (v/v) ampholytes (Pharmalyte 3–10,
Amersham, UK), 1% (v/v) destreak reagent (Amersham) and
a trace amount of bromophenol blue) and loaded onto 70mm
pH 3–10 non-linear immobilized pH gradient (IPG) strips (GE
Healthcare) overnight. IPG strips were focused on a Protean iso-
electric focusing (IEF) cell (BioRad) with linear voltage increases:
250V for 15min; 4000V for 2 h; then up to 20,000V. Follow-
ing IEF, strips were equilibrated (20min) in equilibration buffer
(6M urea, 0.375M Tris, pH 8.8, 2% (w/v) sodium-dodecyl sul-
fate, and 20% (v/v) glycerol) containing 2% (w/v) dithiothre-
itol, and then for 20min in equilibration buffer containing 2.5%
(w/v) iodoacetamide. Equilibrated strips were then subjected to
gel electrophoresis. Fluorescent and colloidal coomassie stained
gel images were captured as described above.
Image Analysis
Quantity One image analysis software (Bio-Rad) was used to
subtract background and quantify optical density for total pro-
tein carbonyl and free thiol content. For each sample, intensity
of fluorescence was normalized to intensity of coomassie stain-
ing. For 2D separations, alignment of gels, spot matching, and
quantification of spot volumes was carried out using Progene-
sis SameSpots image analysis software (Version 4.5; Non-linear
Dynamics, USA).
Protein Digestion and Identification
Gel spots were used for in-gel protein digestion with trypsin. The
extracted peptides were loaded onto a R2 micro column (RP-C18
equivalent) where they were desalted, concentrated and eluted
directly onto a MALDI plate using α-cyano-4-hydroxycinnamic
acid (5mg/ml) as matrix solution in 50% (v/v) acetonitrile
and 5% (v/v) formic acid. Mass spectra of the peptides were
acquired with positive reflectron mass spectrometry (MS) and
MS/MS modes using MALDI-TOF/TOF MS instrument (4800
plus MALDI TOF/TOF analyzer). The collected MS and MS/MS
spectra were analyzed in combined mode using Mascot (version
2.2; Matrix Science, Boston, MA) search engine and SwissProt
(release 02_2013, 539,165 entries) database restricted to 50 ppm
peptide mass tolerance for the parent ions, an error of 0.3 Da for
the fragments, one missed cleavage in peptide masses, and car-
bamidomethylation of Cys and oxidation of Met as fixed and
variable amino acid modifications, respectively. No taxonomy
restrictions were applied. The identified proteins were only con-
sidered if a MASCOT score above 95% confidence was obtained
(p < 0.05) and at least one peptide was identified with a score
above 95% confidence (p < 0.05). This analysis was conducted
by the Analytical Services Unit, Instituto de Tecnologia Química
e Biológica (ITQB), New University of Lisbon, Lisbon, Portugal.
Chymotrypsin-like Proteasome Activity
Chymotrypsin-like activity of the 20S proteasome was mea-
sured fluorometrically in accordance with the manufacturer’s
instructions (Abcam, UK).
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Glycolytic Enzyme Activities
For GAPDH activity measurement, samples were added to
13.5mM sodium pyrophosphate buffer (pH 8.5) containing
30mM sodium arsenate, 0.25mM NAD with 3.325mM DTT.
Samples were incubated at 25◦C for 10min to achieve temper-
ature equilibration and to establish a blank rate, if any. 0.5mM
DL-glyceraldehdye-3-phosphate was added and absorbance was
recorded for 10min at 339 nm. Measured rates were corrected
by measuring the blank rate of the reaction. One unit is defined
as 1µmol NADH generated/minute/mg protein. Similarly, total
LDH activity was calculated as rate of absorbance at 339 nm
produced by oxidation of NADH at 25◦C and pH 7.3 in 0.2M
Tris-HCL buffer containing 1mM sodium pyruvate and 0.22mM
NADH.
HIF-1α and Phospho-MAPK Content
HIF-1α content and phospho-(p)-p38, p-JNK, p-ERK1/2 con-
tent were assayed by an immuno-linked luminescence assay in
accordance with manufacturer’s instructions (Mesoscale Discov-
ery, Gaithersburg, USA). HeLa cells treated with and without
cobalt chloride for 16 h provided positive and negative controls
respectively for the HIF-1α assay. Lysate from Jurkat cells treated
with 1 mol rapamycin for 3 h to activate MAPK phosphatase 1
was used as negative control for the MAPK assay. Lysate from
Jurkat cells treated with 50 nM calyculin A and 200 nM PMA for
15min to stimulate phosphorylation of MAPK proteins was used
as a positive control (Mesoscale Discovery).
Isotonic Muscle Function
Ex Vivo Muscle Preparation
Animals were anesthetized by 5% isoflurane inhalation in air
and euthanized by cervical dislocation. Sternohyoidmuscles were
excised and placed in a bath of Krebs solution (NaCl 120mM,
KCl 5mM, Ca2+ gluconate 2.5mM, MgSO4 1.2mM, NaH2PO4
1.2mM, NaHCO3 25mM, glucose 11.5mM, and 25µM d-
tubocurarine) at room temperature and gassed with carbogen
(95% O2/5% CO2) before mounting in the test bath for assess-
ment of muscle contractile and endurance performance. Whole
intact mouse sternohyoid muscle bundles were arranged between
the electrodes with the sternum anchored at a fixed base and
hyoid bone connected by a non-elastic string to a dual-mode lever
force transducer (Aurora Scientific, Canada) such that fibers were
orientated vertically. Upon placement in the test bath, bundles
were incubated at 35◦C in Krebs solution gassed with carbo-
gen (95% O2/5% CO2). Muscle performance has previously been
shown (Skelly et al., 2010) to be optimal under hyperoxic con-
ditions (95% O2) compared to normoxic conditions (21% O2).
Bundles were equilibrated for 5min in gassed Krebs solution
prior to initiating the experimental protocol.
Protocol
Bundles were set to optimum length (Lo—length at which peak
twitch force occurs) by adjusting the position of the force trans-
ducer with a micro-positioner and stimulating with repeated
single pulses whilst adjusting muscle length until peak twitch
force was reached. Contractile kinetics [time to peak (TTP) and
half-relaxation time (T50)] were measured from the peak twitch
force recordings. After 5min of equilibration, the lever of the
force transducer was set to maximum rigidity (∼500 mN;>100%
load) and a tetanic contraction was elicited by stimulating the
bundle with supra-maximal voltage at 100Hz for 300ms. The
peak isometric force (Fmax) was established allowing determi-
nation of 100% load for isotonic assessments. Shortening con-
tractions were elicited in incremental steps ranging from 0 to
100% load with 1min rest between each step. Peak shortening
velocity (Vmax) was determined during the initial 30ms of short-
ening (see Figure 1) as this is when velocity is greatest (Watchko
et al., 1997; Van Lunteren et al., 2007; Van Lunteren and Pollar-
ine, 2010). Power was determined at each step as the product of
force/cross-sectional area (CSA) x shortening velocity/Lo. Peak
specific work (Wmax) was calculated as force/CSA x shorten-
ing (L/Lo) at the load where the product of these variables was
greatest.
Isotonic Function Data Analysis
Muscle cross-sectional area (CSA) was calculated as the blotted
dry muscle bundle weight divided by the product of Lo and the
specific density which was assumed to be 1.056 g/cm3. Specific
force was calculated as N/cm2. Specific shortening velocity was
calculated as Lo/s. Specific power was calculated as Watts/cm2.
Wmax was calculated as Joules/cm3.
Statistical Analyses
Statistical comparisons of the total mean fluorescence inten-
sity for 1D preparations and FTSC/IAF- and coomassie-labeled
spot volumes (2D) were measured using Student t-tests, Mann-
Whitney U-tests, or One-Way ANOVA as appropriate after test-
ing for normality and equal variance in the data sets. Student
t-test or Mann-Whitney U-test was used as appropriate to com-
pare control and CH groups for chymotrypsin-like activity of the
20S proteasome, and GAPDH and LDH activities. Tissue limi-
tations restricted the measurement of all molecular components
at all three time points of CH exposure. HIF-1α content and
p-MAPK contents were compared between groups by One-Way
FIGURE 1 | Representative profile of sternohyoid peak shortening
velocity. An original record illustrating a representative contraction at 0% load.
Maximum velocity of shortening was calculated during the first 30ms of the
contraction.
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ANOVA followed by Tukey’s multiple comparison post-hoc test,
or the Kruskal-Wallis test followed by Dunn’s multiple com-
parison post-hoc test as appropriate, after testing for normal-
ity and equal variance in the data sets. Statistical comparisons
were performed between groups for sternohyoid contractile and
endurance performance using One-Way ANOVA followed by
Tukey’s multiple comparison post-hoc tests. Power-load relation-
ship was assessed by Two-Way ANOVA followed by Bonferroni’s
post-hoc multiple comparison tests. Linear regression analysis
was performed to assess the relationship between oxidative stress
markers (protein free thiol and carbonyl groups) and sternohy-
oid muscle power. P < 0.05 was the criterion for statistical
significance in all tests.
Results
Animal Model
Hematocrit was significantly (p < 0.001) increased by CH expo-
sure (Table 1). Antioxidant supplementation in animals exposed
to 6 weeks of CH had no effect on hematocrit compared to CH
alone. Animals drank equivalent volumes of water (with or with-
out antioxidant) per day. Body mass decreased after 1 week of
CH exposure but all hypoxic animals returned to a growth curve
equivalent to the control animals for weeks two through to six of
the gas treatments (data not shown).
Total Protein Carbonyl and Free Thiol Content
Significant increases in sternohyoid carbonyl content were
observed after 3 (p < 0.001) and 6 (p < 0.001) weeks of
CH (Figure 2A)—indicative of increased sternohyoid protein
oxidation. Sternohyoid protein free thiol content changes were
bi-phasic (Figure 2B). There was a significant increase in ster-
nohyoid protein free thiol content after 1 (p < 0.05) and 3
(p < 0.01) weeks of CH; however free thiol content was sig-
nificantly lower than control after 6 weeks of CH (p < 0.001).
For comparison, two limb muscles, namely soleus, and extensor
digitorum longus (EDL) were also studied. Unlike the sternohy-
oid, there were no significant changes to the carbonyl content of
the EDL proteome after CH exposure (Figure 3A). There was,
however, significant increases in EDL free thiol content after 1
(p < 0.01), 3 (p < 0.001), and 6 (p < 0.001) weeks of CH—
though the magnitude of the increase is seen to decrease over
time (Figure 3B). Similar to the sternohyoid muscle, but unlike
the EDL, significant increases in soleus protein carbonyl content
were observed after 3 (p < 0.05), and 6 (p < 0.01) weeks of CH
TABLE 1 | Hematocrit values after 1, 3, or 6 weeks of normoxia or chronic
sustained hypoxia (CH).
Normoxia CH P-valuea
HEMATOCRIT (%)
One Week 34 ± 2 52 ± 2 P < 0.001
Three Weeks 38 ± 1 65 ± 1 P < 0.001
Six Weeks 32 ± 1 62 ± 1 P < 0.001
Data are presented as mean ± SEM; n = 8 per group. aStudent unpaired t-test.
(Figure 4A). Soleus protein free thiol content was significantly
increased after 1 (p < 0.001), 3 (p < 0.01), and 6 (p < 0.001)
weeks of CH compared to controls (Figure 4B). Consistent with
EDL, there was a decline in increased free thiol content in the
soleus with progressive CH.
2D Redox Proteomics
In the sternohyoid, 498, 264, and 996 resolved spots were
matched in FTSC-, IAF-labeled and coomassie-stained separa-
tions respectively. A significant relative volume difference was
observed in 87 FTSC, 51 IAF, and 156 coomassie spots compar-
ing control and CH groups (p < 0.05). Proteins were selected
for mass spectrometry analysis based on separation, resolution,
abundance, and overlap in fluorescence-stain and muscle sepa-
rations. Protein smears and gel defects were excluded. Results
for protein remodeling are presented in Table 2 with proteins
grouped according to cellular location and/or function. Selected
spots can be visualized on the representative coomassie stained
gel shown in Figure 5. A change in FTSC and IAF fluorescence
FIGURE 2 | Sternohyoid protein carbonyl and free thiol content after 1,
3, and 6 weeks of sustained hypoxia compared to normoxic controls.
(A) Sternohyoid protein carbonyl content (mean ± SEM) after 1, 3, and 6
weeks of normoxia or sustained hypoxia expressed as normalized
fluorescence intensity; n = 5–8 per group; (B) Sternohyoid protein free thiol
content (mean ± SEM) after 1, 3, and 6 weeks of normoxia or sustained
hypoxia expressed as normalized fluorescence intensity; n = 7–8 per group;
*p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant; Student t-test or
Mann-Whitney test as appropriate. Ctrl, normoxic control; Hypoxia, sustained
hypoxia (FiO2 = 0.1).
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FIGURE 3 | EDL protein carbonyl and free thiol content after 1, 3, and 6
weeks of sustained hypoxia compared to normoxic controls. (A) EDL
protein carbonyl content (mean ± SEM) after 1, 3, and 6 weeks of sustained
hypoxia expressed as normalized fluorescence intensity; n = 4–8 per group;
(B) EDL protein free thiol content (mean ± SEM) after 1, 3, and 6 weeks of
sustained hypoxia expressed as normalized fluorescence intensity; n = 6–8
per group; **p < 0.01, ***p < 0.001, ns, not significant; Student t-test or
Mann-Whitney test as appropriate; Ctrl, normoxic control; Hypoxia, sustained
hypoxia (FiO2 = 0.1).
intensity signal independent of, or differential to, coomassie
signal is indicative of protein redox remodeling.
Sternohyoid Glycolytic Enzyme Activities
Sternohyoid GAPDH activity was significantly increased after 1
week of CH (p < 0.05) but significantly decreased after 3 weeks
of CH (p < 0.01) (data not shown). LDH activity in the sternohy-
oid (data not shown) was significantly increased after 1 week of
CH (p < 0.05).
Sternohyoid Chymotrypsin-like Proteasome
Activity
Chymotrypsin-like proteasome activity was unchanged in the
sternohyoid after 6 weeks of CH (data not shown).
Sternohyoid HIF-1α Content
There was no change in sternohyoid HIF-1α content following 6
weeks of CH with or without antioxidant supplementation (data
not shown).
FIGURE 4 | Soleus protein carbonyl and free thiol content after 1, 3,
and 6 weeks of sustained hypoxia compared to normoxic controls. (A)
Soleus protein carbonyl content (mean ± SEM) after 1, 3, and 6 weeks of
sustained hypoxia expressed as normalized fluorescence intensity; n = 4–8
per group; (B) Soleus protein free thiol content (mean ± SEM) after 1, 3, and 6
weeks of sustained hypoxia expressed as normalized fluorescence intensity;
n = 8 per group; *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant;
Student t-test or Mann-Whitney test as appropriate; Ctrl, normoxic control;
Hypoxia, sustained hypoxia (FiO2 = 0.1).
Sternohyoid Phospho-MAPK Content
There was no change in sternohyoid p-p38 content following
6 weeks of CH with or without antioxidant supplementation
(Figure 6A). However, 6 weeks of CH significantly decreased
sternohyoid p-JNK content compared to control (One-Way
ANOVA (p < 0.01) followed by Tukey’s multiple compari-
son test (p < 0.05); chronic antioxidant supplementation with
either tempol or NAC did not prevent this (Figure 6B). A sim-
ilar effect was observed for sternohyoid p-ERK1/2 content. A
Kruskal-Wallis test revealed a significant difference in the mean
values of the groups. However, Dunn’s multiple comparisons test
revealed no significant differences between pairs (Figure 6C).
Sternohyoid Protein Carbonyl and Free Thiol
Content after Antioxidant Treatment
In the second cohort of animals, significant increases in sternohy-
oid protein carbonyl content were again observed after 6 weeks
of CH (p < 0.001). Chronic antioxidant supplementation with
either Tempol (p < 0.001) or NAC (p < 0.001) significantly
ameliorated the CH-induced increase in protein carbonyl content
Frontiers in Physiology | www.frontiersin.org 6 April 2015 | Volume 6 | Article 122
Lewis et al. Sternohyoid weakness following chronic hypoxia
TABLE 2 | Identifications by mass spectrometry of proteins undergoing significant redox remodeling in the sternohyoid muscle after 6 weeks of
sustained hypoxia.
Spot # Protein Mw (Da) GI number Mascot Matched Sequence Carbonyl Free thiol Expression
score peptides coverage p-value, p-value, p-value,
fold fold fold
ELECTRON TRANSPORT CHAIN
1 Cytochrome bc - 1 complex subunit 1 52,819 341941780 430 6 26% - <0.01, −1.4 <0.001, −2
2 ATP Synthase subunit α 59,716 416677 997 6 53% - - <0.01, +1.5
TCA CYCLE
3 Aconitase hydratase 85,410 60391212 1210 11 41% <0.01, +1.4 <0.001, −2 <0.01, −2.6
4 2-oxo-glutarate dehydrogenase, mt 116,375 146345472 477 4 22% - <0.01, −2.4 <0.01, +2.8
GLYCOLYSIS
5 Fructose bis-phosphate aldolase A 39,331 113607 588 3 70% - <0.01, −2.9 -
6 Glyceraldehyde-3-phosphate dehydrogenase 35,787 120702 531 4 48% - <0.01, −1.6 <0.001, −2
7 Phosphoglycerate kinase 1 44,534 1730519 534 4 45% - - <0.01,+1.7
8 Phosphoglycerate mutase 2 28,809 6093745 1010 9 57% - - <0.01, +1.7
9 Pyruvate kinase isozymes M1/M2 57,305 146345448 837 6 53% <0.01, −1.2 - <0.01, +1.3
PHOSPHAGEN AND LIPID METABOLISM
10 Glycerol-3-phosphate dehydrogenase [NAD(+)] 37,548 121557 412 3 48% - <0.01, −2 <0.01, −2.6
11 Creatine kinase m-type 43,014 124056470 784 7 42% <0.01, +1.2 - <0.01, −1.2
STRESS RESPONSE AND IRON HOMEOSTASIS
12 Glycogen phosphorylase 97,225 14916635 1450 13 47% <0.01, −1.3 - <0.01, +4.1
13 90kDa heat shock protein 83,229 341941065 742 6 31% - - <0.01, −1.3
14 Alpha crystallin B chain 20,056 6166129 761 7 65% <0.01, +1.2 - -
15 Myoglobin 17,059 127676 923 7 43% - - <0.01, −1.7
16 Serotransferrin 76,674 21363012 121 1 17% <0.01, −1.4 <0.01, +1.8 -
17 Carbonic anhydrase III 29,348 30581036 966 8 71% <0.01, +1.2 <0.01, -2.7 <0.01, +1.9
18 Albumin 68,648 5915682 1340 11 53% - - <0.01, −1.8
CROSS-BRIDGE AND SARCOPLASMIC RETICULUM
19 Calsequestrin 46,420 341940315 543 4 19% <0.01, −1.5 - <0.01, −2.3
FIGURE 5 | Representative image of 2D-PAGE sternohyoid muscle
protein profile after coomassie staining of proteins. A molecular mass
marker ranging from 14 to 116 kDa is shown for size reference and isoelectric
point is indicated along the range pH 10-3. Spot numbers match those
presented in Table 2.
(Figure 7A). Similarly, sternohyoid protein free thiol content was
significantly lower than control after 6 weeks of CH (p < 0.01)
and antioxidant treatment with Tempol (p < 0.001) and NAC
(p < 0.05) ameliorated this effect (Figure 7B).
Sternohyoid Muscle Function
There are no significant differences observed across groups for
contractile kinetics, twitch force, Vmax, Wmax, or isotonic
fatigue index (Table 3) as determined by One-Way ANOVA or
Kruskal-Wallis test; however, CH exposure increased the con-
traction time, and decreased endurance (Table 3). NAC supple-
mentation in CH increased peak twitch force, Vmax, Wmax,
and endurance (Table 3). Fmax is significantly different across
groups; decreased in CH compared to control and significantly
increased by NAC supplementation in CH compared to CH
alone as revealed by Tukey’s multiple comparison post-hoc test
(Table 3).
Sternohyoid muscle isotonic contractile function (power) was
significantly depressed by CH exposure (Figure 8; Two-Way
ANOVA: gas treatment: p < 0.001). Significant correlations were
observed for oxidative stress markers and sternohyoid muscle
function (Figure 9). The deleterious effects of CH exposure
on sternohyoid function were prevented with antioxidant
supplementation in CH using either tempol or NAC (Figure 8).
Discussion
This is the first study to identify proteins in an upper air-
way muscle undergoing redox remodeling following exposure
to CH. CH decreased sternohyoid force- and power-generating
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FIGURE 6 | Sternohyoid phospho-MAPK contents after 6 weeks of
normoxia and sustained hypoxia ± chronic antioxidant
supplementation. (A) Sternohyoid phospho-p38 content (mean ± SEM)
expressed as normalized relative luminescence units; n = 5–7 per group; (B)
Sternohyoid phospho-JNK content (mean ± SEM expressed as normalized
relative luminescence units; n = 5–7 per group; (C) Sternohyoid phospho-ERK
1/2 content (mean ± SEM) expressed as normalized relative luminescence
units; n = 5–7 per group; *p < 0.05 and **p < 0.01 vs. control, Tukey’s multiple
comparison test; Ctrl, normoxic control; Hypoxia, sustained hypoxia (FiO2 =
0.1); Tempol, tempol + sustained hypoxia; NAC, NAC + sustained hypoxia;
RLU, relative luminescence units.
capacity. Antioxidant supplementation prevented CH-induced
sternohyoid dysfunction. The main findings of this study are:
(1) CH induces temporal changes in protein carbonylation and
free thiol oxidation in the sternohyoid, responses different to
that seen in limb muscles; (2) Proteins key to muscle contrac-
tion, metabolism, and homeostasis are redox-modified in the
sternohyoid following 6 weeks of CH; (3) Glycolytic enzyme
activities are temporally affected in the sternohyoid following
progressive CH exposure; (4) CH has no effect on sternohy-
oid HIF-1α content; (5) CH decreases p-JNK in sternohyoid
FIGURE 7 | Sternohyoid protein carbonyl and free thiol content
following 6 weeks of normoxia and sustained hypoxia ± chronic
antioxidant supplementation. (A) Sternohyoid protein carbonyl content
(mean ± SEM) expressed as normalized fluorescence intensity; n = 5–7 per
group; (B) Sternohyoid protein free thiol content (mean ± SEM) expressed as
normalized fluorescence intensity; n = 5–7 per group; **p < 0.05 and
***p < 0.001 vs. control, #p < 0.05 and ###p < 0.001 vs. hypoxia, Tukey’s
multiple comparison test; Ctrl, normoxic control; Hypoxia, sustained hypoxia
(FiO2 = 0.1); Tempol, tempol + sustained hypoxia; NAC, NAC + sustained
hypoxia.
independent of antioxidant status; (6) CH causes sternohyoid
muscle dysfunction; (7) Oxidative stress markers and muscle
function were significantly correlated; (8) Both protein oxidation
and contractile impairment following CH are fully reversed by
chronic antioxidant supplementation.
Muscle Redox Status
In skeletal muscle adaptation to high altitude and respiratory dis-
eases featuring hypoxia, ROS have been shown to cause protein
redox remodeling and to modify protein function with resul-
tant changes in metabolic processes, homeostasis and contrac-
tile performance (Zuo and Clanton, 2005; Marin-Corral et al.,
2009; Murray, 2009; Chaudhary et al., 2012; Levine et al., 2013;
Puig-Vilanova et al., 2015). However, the cause and motive for
increased ROS production is unclear and may differ in skeletal
muscles given their varied functional roles. In the present study,
we observed time-dependent increases in protein oxidation (both
increased carbonyl content and decreased free thiol content)
in CH-exposed sternohyoid muscle (differential to responses in
limb muscles, which is likely pivotal for time-dependent and
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TABLE 3 | Sternohyoid muscle contractile properties after 6 weeks of normoxia and sustained hypoxia ± chronic antioxidant supplementation.
Normoxia Hypoxia Tempol NAC P-Valuea
TTP (ms) 9 ± 0 10 ± 0 11 ± 1 10 ± 0 ns
T50 (ms) 11 ± 1 11 ± 1 14 ± 3 12 ± 2 ns
Pt (N/cm2) 2.5 ± 0.4 1.6 ± 0.2 1.9 ± 0.2 3.0 ± 0.9 ns
Fmax (N/cm2) 12.3 ± 1.5 8.0 ± 0.6* 11.0 ± 0.3 16.0 ± 2.3## <0.01
Vmax (Lo/s) 5.4 ± 0.7 5.2 ± 0.9 6.1 ± 0.7 6.1 ± 0.4 ns
Wmax (J/cm3) 0.6 ± 0.1 0.6 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 ns
Fatigue Index (% of initial power) 63 ± 14 36 ± 7 33 ± 11 46 ± 12 ns
Data are presented as mean ± SEM; n = 5–8 per group; aOne Way ANOVA, *p < 0.05 vs. Normoxia and ##p 0.01 vs. Hypoxia, Tukey’s post-hoc multiple comparison test; ns, not
significant; Hypoxia, 6 weeks of sustained hypoxia (FiO2 = 0.1); Tempol, tempol + hypoxia; NAC, NAC + hypoxia.
FIGURE 8 | Sternohyoid power-load relationship following 6 weeks of
normoxia and sustained hypoxia ± chronic antioxidant
supplementation. Sternohyoid specific power (mean ± SEM) expressed as
Watts/CSA (cm2) as a function of load expressed as a percentage of peak
force (force/peak force*100); n = 5–7 per group; Ctrl, normoxic control; Hyp,
sustained hypoxia (FiO2 = 0.1); Tempol, tempol + sustained hypoxia; NAC,
NAC + sustained hypoxia. P-values shown for two factor (treatment × load)
analysis of variance highlighting a significant effect of 6 weeks of sustained
hypoxia on sternohyoid power-load relationship. Antioxidant supplementation
reversed the effects of hypoxia.
differential structural and functional remodeling reported in pre-
vious studies (El-Khoury et al., 2003, 2012; Faucher et al., 2005;
Gamboa and Andrade, 2010, 2012; McMorrow et al., 2011; Car-
berry et al., 2014). This, in turn, may be of clinical significance
given that CH is potentially implicated in the progression of
respiratory diseases.
Clearly there is differential muscle protein redox remodeling
which appears unrelated to fiber type per se given the similarities
between the EDL and sternohyoid muscles, and unrelated to
respiratory vs. limb muscle differences per se given the differ-
ences observed in the EDL compared with the soleus. As the
soleus is a postural muscle, it exhibits greater contractile activ-
ity than the EDL which is used for more powerful movements
of the limbs. The combination of activity and hypoxic exposure
is potentially synergistic in driving protein oxidation, with reflex
hyperventilation and hypoxia combining to drive protein oxi-
dation in the sternohyoid. Furthermore, a comparison of basal
carbonyl signals from sternohyoid and limb muscle proteomes
suggests that basal workload of a given muscle is more important
in determining carbonylation of proteins than fiber type per se.
2D redox proteomic profiling of the sternohyoid muscle after
6 weeks of CH exposure reveals key proteins in muscle that
are targeted by ROS, many of which are redox modified in
COPDmuscle (Marin-Corral et al., 2009). It is clear from Table 2
that extensive remodeling occurs to mitochondrial, metabolic,
and associated proteins, suggesting that the mitochondria are
the primary source of remodeling stress. Reflex hyperventilation
increases metabolic demand and subsequent metabolic substrate
flux to the respiratory chain. With hypoxia, stockpiling of elec-
trons occurs, increasing electron leak and subsequent ROS for-
mation. This is supported by the findings of decreased muscle
mitochondrial density andmitochondrial remodeling in hypoxia,
high altitude, and respiratory-related diseases (Hoppeler et al.,
1990, 2003; Gosker et al., 2000; Wijnhoven et al., 2006; Viganò
et al., 2008; Gamboa and Andrade, 2010, 2012). The fold change
in free thiol content following 1 week of CH is greatest in
soleus>EDL>sternohyoid suggesting that fiber type, more so
than contractile activity, is key to this change.
EDL free thiol content remains elevated above control whereas
carbonyl content was unchanged after 6 weeks of CH; however
the pattern of change is similar to the sternohyoid and soleus
muscles. It is likely to be a combination of hypoxia, muscle fiber
composition, and workload in hypoxia that accounts for the dif-
ferential changes in respiratory and limb muscle protein oxi-
dation and functional changes. In keeping with the notion of
muscle specific effects of CH, other studies have reported dif-
ferential effects of oxidation, based on carbonyl and thiol mea-
surements as well as other indicators of altered cellular oxida-
tive/reductive state which are proposed to depend on the activity
and/or local cellular environment of the relevant protein (Hay-
cock et al., 1998; Kadiiska et al., 2005; El-Shafey et al., 2011). See
additional discussion in the supplementary file.
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FIGURE 9 | Relationship between sternohyoid power and oxidative
stress markers. Relationship between sternohyoid specific peak power and
muscle oxidative stress markers [protein free thiol content (A) and carbonyl
content (B)] plotting data from all animals in the second cohort of studies;
n = 24. Note the correlation coefficients and statistically significant
relationships.
Muscle Redox Signaling
Decreased sternohyoid GAPDH activity with progressive
hypoxia is consistent with the decreased expression measured by
proteomic profiling after 6 weeks of CH. CH-induced changes
in LDH activity in the sternohyoid follow a similar pattern to
GAPDH. As muscle function and metabolism are intrinsically
interlinked through HIF signaling (Semenza et al., 1994; Vogt
et al., 2001; Kim et al., 2006), one might have expected a
CH-induced increase in HIF-1α content. However, decreased
GAPDH expression and decreased GAPDH and LDH activities
observed in the sternohyoid muscle of our mouse model are
suggestive of decreased HIF-1α content. Interestingly, after 6
weeks of CH exposure we observed that there was no change in
sternohyoid HIF-1α content. It is plausible that the degree of
hypoxia experienced by the sternohyoid may change temporally
with acclimatization to hypoxia such that HIF-1α may have been
activated earlier in the exposure. Of note, for example, GAPDH
activity is increased in sternohyoid muscle after 1 but not 3 weeks
of CH. Protein carbonylation is elevated in CH sternohyoid after
6 weeks suggesting that although ROS are presumably elevated
in the muscle there is no ROS-dependent HIF-1α activation.
Moreover, antioxidant supplementation did not affect HIF-1α
content in CH sternohyoid. Thus, our results suggest that redox
modulation of sternohyoid metabolism and function is HIF-1α
independent.
The MAPK proteins are involved in a diverse array of
cellular signaling events and are vital to muscle growth and
homeostasis. p38 activity in muscle is strongly associated with
promoting atrophy in COPD limb muscle (Lemire et al.,
2012) and is potentially required for hypoxia signaling of HIF
via mitochondrial ROS production (Emerling et al., 2005).
However, neither HIF-1α content nor chymotrypsin-like 20S
proteasome activity changed in the sternohyoid muscle following
CH. Indeed, hypertrophy of fast fibers in the sternohyoid
is reported following CH exposure in the rat (McMorrow
et al., 2011) suggesting enhanced protein synthesis. This is
especially interesting, as the present study has established for
the first time, that the CH sternohyoid has decreased (not
increased) power-generating capacity, highlighting a potent
redox-dependent inhibitory effect of CH on the contractile
machinery of the airway dilator muscle, rather than CH-induced
muscle atrophy.
p-JNK content is decreased in the sternohyoid following CH
exposure. Differential regulation of p38 and JNK occurs at the
MAP2K level and is potentially influenced by contractile activ-
ity and mechanical stress (Sawada et al., 2001). The combina-
tion of hypoxic/redox stress, muscle fiber type combination, and
mechanical activity of the sternohyoid is likely important in
determining the stress kinase response to CH exposure. A ROS/p-
JNK-dependent mechanism is implicated in CH-induced ster-
nohyoid dysfunction but it is important to note that antioxidant
supplementation did not prevent the CH-induced decrease in p-
JNK (or p-ERK1/2), whereas antioxidants prevented sternohyoid
redox stress and contractile dysfunction following CH exposure.
Sternohyoid Isotonic Performance
The sternohyoid force- and power-generating capacity was sig-
nificantly depressed by CH exposure. Muscle oxidative stress
markers and contractile power were significantly correlated;
moreover, antioxidant supplementation during CH exposure
prevented both protein redox stress and contractile dysfunction.
Therefore, we posit that CH-induced redox remodeling of key
proteins in metabolism and the contractile apparatus is central
to CH-induced sternohyoid muscle dysfunction. Concerning the
potential clinical relevance of our findings, sternohyoid dysfunc-
tion could serve to increase obstructive airway events in vivo—
further disrupting respiratory homeostasis in diseases charac-
terized by hypoxic stress. We speculate that CH-induced redox
remodeling and functional deficit in pharyngeal dilator muscles
potentially underpins the higher prevalence of OSA observed in
COPD patients (the overlap syndrome) (Owens and Malhotra,
2010).
Summary and Conclusions
This study highlights the application of a redox proteomics
approach to a translational animal model of hypoxia. CH expo-
sure causes progressive redox remodeling in the sternohyoid
(upper airway dilator) muscle with differential responses to limb
muscles. CH results in metabolic protein structural remodeling
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with resultant changes in enzyme activity. Redox and expres-
sion changes were shown to occur to various protein chaper-
ones including those important to cross-bridge maintenance.
Ultimately, it appears that CH-induced redox changes result
in functional deficit in the sternohyoid, given that antioxidant
supplementation during CH exposure prevents both protein
stress and functional impairment. We hypothesize a pivotal role
for ROS in pharyngeal dilator muscle structural and functional
(mal)adaptations to CH. The putative role of hypoxia in driv-
ing respiratory muscle remodeling in human respiratory disease
warrants investigation.
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